GPT Healthcare Stock Screener | Share Price & Fundamental Analysis
GPTHEALTH
Hospitals
Share Price NSE
₹130.88
▲
5.05 (4.01%)
Share Price BSE
₹131.10
▲
4.55 (3.60%)
Track GPT Healthcare share price live with TickJournal's free stock screener.
Analyze GPT Healthcare share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
GPT Healthcare Market Cap
₹1,011.90 Cr.
GPTHEALTH P/E Ratio (TTM)
-
GPT Healthcare P/B Ratio
5.10
EPS (TTM)
₹5.22
Dividend Yield
2.67%
Debt to Equity
0.76
GPTHEALTH 52 Week High
₹183.16
GPT Healthcare 52 Week Low
₹115.31
Operating Margin
-
Profit Margin
-
GPTHEALTH Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹323.00
Total Equity
₹158.00
GPT Healthcare Share Price History - Stock Screener Chart
Screen GPTHEALTH historical share price movements with interactive charts. Analyze price trends and patterns.
GPT Healthcare Company Profile - Fundamental Screener
Screen GPT Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GPTHEALTH shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE486R01017
GPT Healthcare Balance Sheet Screener
Screen GPTHEALTH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2022 | 2021 | 2020 |
|---|---|---|---|
| Assets | |||
| Total Assets | 323 | 317 | 309 |
| Current Assets | 86 | 86 | 63 |
| Fixed Assets | 220 | 220 | 226 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 97 | 123 | 117 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 158 | 134 | 127 |
| Share Capital | 80 | 18 | 18 |
| Reserves & Surplus | 78 | 76 | 69 |
GPT Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen GPT Healthcare income statement and profit fundamentals.
Analyze GPTHEALTH quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for GPT Healthcare share price evaluation.
| Item | None-None | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|
| Revenue | 0 | 342 | 249 | 216 |
| Expenses | 0 | 264 | 194 | 176 |
| EBITDA | 0 | 79 | 55 | 40 |
| Operating Profit % | 0.00% | 22.00% | 20.00% | 17.00% |
| Depreciation | 0 | 14 | 13 | 11 |
| Interest | 0 | 11 | 14 | 14 |
| Profit Before Tax | 0 | 54 | 29 | 15 |
| Tax | 0 | 12 | 8 | 4 |
| Net Profit | 0 | 42 | 21 | 11 |
| EPS | 0.00 | 5.22 | 7.92 | 4.11 |
GPT Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen GPTHEALTH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2022-March | 2021-March | 2020-March |
|---|---|---|---|
| Operating Activities | 66 | 43 | 42 |
| Investing Activities | -5 | -17 | -54 |
| Financing Activities | -57 | -22 | 12 |
| Net Cash Flow | 4 | 4 | -1 |
GPT Healthcare Shareholding Pattern Screener
See GPT Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check GPT Healthcare promoter holding and ownership changes for GPTHEALTH on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Feb | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% |
| FII Holding | 4.48% | 4.96% | 3.20% | 2.74% | 0.00% | 6.68% | 5.38% | 4.70% |
| DII Holding | 11.35% | 9.32% | 6.46% | 6.20% | 10.07% | 12.81% | 13.08% | 11.99% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.55% | 16.65% | 18.89% | 19.11% | 17.14% | 12.16% | 13.61% | 15.07% |
| Other Holding | 3.04% | 3.50% | 5.87% | 6.38% | 7.22% | 2.78% | 2.35% | 2.66% |
| Shareholder Count | 68,365 | 67,060 | 67,617 | 66,626 | 9 | 76,664 | 71,293 | 74,737 |
GPT Healthcare Share Dividend Screener - Share Yield Analysis
Check GPT Healthcare dividend history with payout and yield data.
View GPT Healthcare dividend details including ex-dates and amounts for GPTHEALTH stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.50 | 2.17% |
| 2024-March | ₹3.50 | 2.38% |
| 2023-March | ₹5.00 | 2.84% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
GPT Healthcare Stock Index Membership
See which indices include GPT Healthcare stock.
Check GPTHEALTH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY IPO
GPT Healthcare Market Events Screener - Corporate Actions
Get GPT Healthcare corporate actions including splits, bonuses, and buybacks.
Check GPT Healthcare stock events that may affect GPTHEALTH share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-02 | 2026-02-02 | Quarterly Result Announcement | NA | -0.46% |
| 2025-11-14 | 2025-11-14 | Dividend | ₹ 1.00 /share | -2.65% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -1.65% |
| 2025-08-06 | 2025-08-06 | Quarterly Result Announcement | NA | 11.56% |
| 2025-08-05 | 2025-08-05 | Annual General Meeting | NA | 18.32% |
| 2025-07-29 | 2025-07-29 | Dividend | ₹ 1.50 /share | 2.99% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | -1.20% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -9.69% |
| 2024-11-28 | 2024-11-28 | Dividend | ₹ 1.00 /share | 6.38% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -5.82% |
| 2024-07-25 | 2024-07-25 | Annual General Meeting | NA | 3.38% |
| 2024-07-18 | 2024-07-18 | Dividend | ₹ 1.50 /share | 5.20% |
| 2024-04-02 | 2024-04-02 | Dividend | ₹ 1.00 /share | 6.01% |
GPT Healthcare Competitors Screener - Peer Comparison
Screen GPTHEALTH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 105,214 | 56.38 | 21,994 | 14.76% | 1,505 | 43.82 |
| Max Healthcare Institute | 91,922 | 64.79 | 7,184 | 28.65% | 1,076 | 33.15 |
| Fortis Healthcare | 59,547 | 60.72 | 7,850 | 13.25% | 809 | 34.81 |
| Aster DM Healthcare | 34,098 | 95.08 | 4,287 | 15.12% | 337 | 52.91 |
| Narayana Hrudayalaya | 33,209 | 42.59 | 5,575 | 12.29% | 790 | 39.62 |
| Global Health | 26,890 | 52.36 | 3,771 | 12.59% | 481 | 39.89 |
| Krishna Institute of Medical Sciences | 25,059 | 79.56 | 3,067 | 21.98% | 415 | 40.26 |
| Dr. Agarwal's Health Care | 13,211 | 82.40 | 1,757 | 27.64% | 110 | 39.56 |
| Rainbow Childrens Medicare | 11,674 | 44.92 | 1,567 | 17.46% | 244 | 46.28 |
| Park Medi World | 8,517 | 31.60 | 1,426 | 12.90% | 213 | 53.64 |
GPT Healthcare Company Announcements - News Screener
Screen GPTHEALTH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-03-29 | Closure of Trading Window | - |
| 2026-03-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-02 | Un-Audited Financial Results For The 3Rd Quarter And Nine Months (Q3 & 9MFY26) Ended December 31 2025 | - |
| 2026-02-02 | Board Meeting Outcome for Outcome Of Board Meeting Held On February 2 2026 | - |
| 2026-01-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-27 | Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Along With Limited Review Report Of The Statutory Auditors Thereon Of The Company For The 3Rd Quarter And Nine Months (Q3 & 9MFY26) Ended December 31 2025. | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-29 | Closure of Trading Window | - |
| 2025-12-26 | Appointment Of MUFG Intime India Private Ltd For Providing Investor Relations Advisory Services. | - |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |